BRPI9909018B8 - processo para a síntese de um peptídeo - Google Patents

processo para a síntese de um peptídeo

Info

Publication number
BRPI9909018B8
BRPI9909018B8 BRPI9909018A BRPI9909018A BRPI9909018B8 BR PI9909018 B8 BRPI9909018 B8 BR PI9909018B8 BR PI9909018 A BRPI9909018 A BR PI9909018A BR PI9909018 A BRPI9909018 A BR PI9909018A BR PI9909018 B8 BRPI9909018 B8 BR PI9909018B8
Authority
BR
Brazil
Prior art keywords
peptide
peptides
synthesis
present
fragments
Prior art date
Application number
BRPI9909018A
Other languages
English (en)
Inventor
Bray Brian
Mader Catherine
Merutka Gene
Lichty Maynard
Kang Myung-Chol
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trimeris Inc filed Critical Trimeris Inc
Priority claimed from PCT/US1999/006230 external-priority patent/WO1999048513A1/en
Publication of BRPI9909018B1 publication Critical patent/BRPI9909018B1/pt
Publication of BRPI9909018B8 publication Critical patent/BRPI9909018B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

"processo para a síntese de um peptídeo, conjunto de fragmentos de peptídeo,e,peptídeo". a presente invenção refere-se, primeiro, aos processos de síntese de peptídeos, em particular de t-20 (também referido como "dp178"; seq id no: 1) e de peptídeos semelhantes a t-20. tais processos utilizam procedimentos de síntese em fases liquida e sólida e combinam grupos de fragmentos de peptídeo específicos para dar o peptídeo de interesse. a presente invenção refere-se em adição aos fragmentos de peptídeo individuais que atuam como intermediários na síntese de peptídeos de interesse (por exemplo, t-20). a presente invenção ainda refere-se adicionalmente aos grupos de tais fragmentos de intermediário de peptídeo que podem ser empregados juntos para produzir t-20 de comprimento total e peptídeos semelhantes a t-20.
BRPI9909018A 1998-03-23 1999-03-22 processo para a síntese de um peptídeo BRPI9909018B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US09/045920 1998-03-23
US09/071877 1998-05-01
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
PCT/US1999/006230 WO1999048513A1 (en) 1998-03-23 1999-03-22 Methods and compositions for peptide synthesis

Publications (2)

Publication Number Publication Date
BRPI9909018B1 BRPI9909018B1 (pt) 2019-04-09
BRPI9909018B8 true BRPI9909018B8 (pt) 2021-05-25

Family

ID=21940553

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9909018A BRPI9909018B8 (pt) 1998-03-23 1999-03-22 processo para a síntese de um peptídeo

Country Status (4)

Country Link
US (2) US6281331B1 (pt)
JP (1) JP4755713B2 (pt)
KR (1) KR100633214B1 (pt)
BR (1) BRPI9909018B8 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU3334001A (en) 2000-02-10 2001-08-20 Panacos Pharmaceuticals Inc Assay for detection of viral fusion inhibitors
US20050065319A1 (en) * 2000-12-19 2005-03-24 Baroudy Bahige M. Combination method for treating viral infections
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
KR100451432B1 (ko) * 2002-07-12 2004-10-06 강충경 Ｔ-20 펩타이드의 생물학적 제조방법
RU2296769C2 (ru) * 2002-07-24 2007-04-10 Ф.Хоффманн-Ля Рош Аг Пэгилированный полипептид т20
EP1546193A1 (en) * 2002-07-24 2005-06-29 F. Hoffmann-La Roche Ag Pegylated t1249 polypeptide
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
EA007918B1 (ru) 2002-09-24 2007-02-27 Франтиэ Биотекнолоджиз Ко., Лтд. Пептидные производные-ингибиторы слияния при вич-инфекции
US20040076637A1 (en) * 2002-09-27 2004-04-22 Delmedico Mary Kay HIV-derived HR1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus
US7556813B2 (en) * 2002-09-27 2009-07-07 Trimeris, Inc. Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
US20040063856A1 (en) * 2002-09-30 2004-04-01 Bohling James Charles Resin for solid phase synthesis
WO2004035808A2 (en) * 2002-10-16 2004-04-29 Panacos Pharmaceuticals, Inc. Method for detecting viral inactivating agents
US20040158037A1 (en) * 2003-02-12 2004-08-12 Bohling James Charles Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
US20050281829A1 (en) * 2003-05-06 2005-12-22 Hehir Cristina A T Fc chimeric proteins with anti-HIV drugs
WO2004100882A2 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
PL2077121T3 (pl) * 2003-05-06 2011-07-29 Syntonix Pharmaceuticals Inc Białka chimeryczne o strukturze czynnik krzepliwości krwi VII-FC do leczenia zaburzenia hemostatycznego
KR20050024730A (ko) * 2003-09-01 2005-03-11 코바이오텍 (주) Ｔ―２０ 펩타이드 코딩 유전자를 포함하는 재조합대장균의 고농도 세포 배양 방법 및 이로부터 생산된ｔ―２０ 펩타이드의 분리 및 정제 방법
EP1701972B1 (en) * 2003-12-31 2008-10-08 F. Hoffmann-La Roche Ag Process and systems for recovery of peptides
WO2005063799A2 (en) * 2003-12-31 2005-07-14 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
WO2005063800A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Peptide synthesis using decanting filter
WO2005063792A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support
DE602004009710T2 (de) * 2003-12-31 2008-08-07 F. Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
CA2551082A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
US20060051396A1 (en) 2004-06-16 2006-03-09 Affinergy, Inc. Biofunctional coatings
WO2006045503A1 (en) 2004-10-19 2006-05-04 Lonza Ag Method for solid phase peptide synthesis
CN101133077B (zh) * 2004-12-30 2012-09-05 弗·哈夫曼-拉罗切有限公司 使用肽中间片段合成肽t-20
WO2006069779A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Preparing of peptides with excellent solubility
CA2593864C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis using peptide intermediate fragments iii
WO2006069697A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Colorimetrically assessing peptide characteristics
ES2329270T3 (es) * 2004-12-30 2009-11-24 F. Hoffmann-La Roche Ag Sintesis del peptido t-1249 utilizando fragmentos intermediarios del ipeptido.
MX2007012505A (es) * 2005-04-08 2007-12-06 Lonza Ab Sintesis peptidica de helices alfa sobre una resina peg.
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
EP1968995A1 (en) * 2005-12-30 2008-09-17 F. Hoffmann-la Roche AG Methods for the synthesis of arginine-containing peptides
AR059300A1 (es) * 2006-02-02 2008-03-26 Trimeris Inc Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas
TW200745163A (en) * 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
EP2013223A2 (en) * 2006-05-03 2009-01-14 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
JP4537495B2 (ja) * 2006-06-23 2010-09-01 エフ．ホフマン−ラ ロシュ アーゲー インスリン分泌性ペプチドの合成
MX2009010689A (es) * 2007-04-03 2009-12-14 Trimeris Inc Formulaciones novedosas para el suministro de agentes terapeuticos de peptidos antivirales.
CN101790535A (zh) * 2007-06-29 2010-07-28 隆萨股份公司 制备普兰林肽的方法
WO2009014177A1 (ja) * 2007-07-25 2009-01-29 Ajinomoto Co., Inc. ジベンゾフルベン誘導体の淘汰方法
EA201070231A1 (ru) * 2007-08-09 2010-10-29 Синтоникс Фармасьютикалз, Инк. Иммуномодулирующие пептиды
WO2009042194A2 (en) * 2007-09-25 2009-04-02 Trimeris, Inc. Methods of synthesis for therapeuthic anti-hiv peptides
CA2703113A1 (en) * 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
WO2009094636A2 (en) * 2008-01-25 2009-07-30 The University Of North Carolina At Chapel Hill Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway
WO2010014909A1 (en) * 2008-08-01 2010-02-04 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination
US9296805B2 (en) 2009-06-18 2016-03-29 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
WO2011031662A1 (en) 2009-09-08 2011-03-17 Kent Stephen B H Ester insulin
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
AU2011274423B2 (en) 2010-07-09 2016-02-11 Bioverativ Therapeutics Inc. Chimeric clotting factors
EA037906B1 (ru) 2013-03-15 2021-06-04 Биовератив Терапьютикс Инк. Препараты полипептида фактора ix
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
US20180154007A1 (en) 2015-05-20 2018-06-07 Syracuse University Glycemic Control Using Intrinsic Factor Bound to A Vitamin B12 Conjugate of a Glucagon-Like Peptide-1 Receptor Agonist
WO2016187512A1 (en) 2015-05-20 2016-11-24 Syracuse University Compositions and methods for enhancing peptide stability against protease digestion
CN110546155B (zh) * 2017-03-31 2023-06-23 浜理药品工业株式会社 肽的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
NZ254640A (en) 1992-07-20 1997-04-24 Univ Duke Hiv protein fragments of transmembrane glycoprotein gp41 (dp-107) with antiviral activity and their use
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
DE69735991D1 (de) * 1996-02-09 2006-07-06 Hoffmann La Roche Herstellung eines vip-analogen
NZ507083A (en) * 1998-03-23 2003-10-31 Trimeris Inc Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides

Also Published As

Publication number Publication date
US6015881A (en) 2000-01-18
JP2010065044A (ja) 2010-03-25
KR100633214B1 (ko) 2006-10-11
JP4755713B2 (ja) 2011-08-24
BRPI9909018B1 (pt) 2019-04-09
US6281331B1 (en) 2001-08-28
KR20010042131A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
BR9909018A (pt) Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
BR0012249A (pt) Método papa sintetizar um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
ES2054878T3 (es) Expresion de la proapolipoproteina a-i humana.
ATE328069T1 (de) Phosphopantethenyltransferasen und deren verwendungen
BRPI9915679A8 (pt) Composições e métodos para aumentar a mineralização óssea
DK0585285T3 (da) Stabiliserede enzymer
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
BR0206587A (pt) Processo para a produção de uma composição de pantotenato livre de hmbpa, produto, composição de pantotenato livre de hmbpa, composição sintetizada por um microorganismo possuindo uma rota biossintética de pantotenato desregulada, microorganismo recombinante para a produção de composições de pantotenato livres de hmbpa, e, processo para a produção de uma composição de pantotenato: hmbpa seletivamente misturada
BR0115036A (pt) Processo para a preparação de um composto
CO4600707A1 (es) Metodo para preparar palmitoilo de glucosa en presencia de aciltransferasa
DE69623786D1 (de) Mch2, EINE APOPTOTISCHE CYSTEIN-PROTEASE, ZUSAMMENSETZUNGEN FÜR IHRE PRÄPARATION UND METHODEN FÜR IHRE VERWENDUNG
GR3023593T3 (en) Protein structure of the plant toxin gelonin
AU580350B2 (en) Process for synthesising peptides
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
BR9901089A (pt) Processo para a preparação de ácidos hidroxâmicos.
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
TW200700555A (en) Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol b
ATE315656T1 (de) Endothelinkonversionsenzym (ece)
BR9909576A (pt) Genes de receptor de transferrina de moraxella
BR9914775A (pt) Processo quìmico para preparação deintermediários